tiprankstipranks
Trending News
More News >
Mannatech Inc. (MTEX)
NASDAQ:MTEX
US Market

Mannatech (MTEX) AI Stock Analysis

Compare
77 Followers

Top Page

MTEX

Mannatech

(NASDAQ:MTEX)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - 5.2)
Rating:46Neutral
Price Target:
$9.00
▲(13.21% Upside)
The score is primarily weighed down by weak financial performance: declining revenue, negative margins/ROE, and negative operating and free cash flow. Technicals are only mildly supportive (price above key moving averages but negative MACD), while valuation is pressured by losses reflected in the negative P/E.
Positive Factors
High gross profit margin
A 75.7% gross margin signals durable product-level profitability and pricing power in supplements/skincare. High gross margins provide a buffer to absorb sales volatility and can fund marketing and product development if operating expenses are controlled over the medium term.
Manageable leverage
Debt-to-equity near 0.9 implies moderate leverage that preserves financial flexibility. This level allows the company to access debt financing for inventory, distributor support, or product investment without creating immediate solvency pressure, assuming cash flow can be stabilized.
Direct-selling (MLM) distribution
An established MLM direct-sales model creates recurring, community-driven demand and lower fixed retail costs. Durable distributor networks can sustain repeat purchases and organic growth if retention and recruitment economics remain healthy, advantaging margins over retail channels.
Negative Factors
Declining revenue trend
Sustained revenue declines shrink scale, increasing per-unit overhead and weakening distributor economics. Over several quarters, falling top line makes it harder to fund marketing and distributor incentives, undermining the long-term viability of a network-sales model.
Negative operating and free cash flow
Persistent negative operating and free cash flow erodes liquidity and forces reliance on external financing or asset sales. Over months, this limits reinvestment in product development and distributor support, increasing business risk and constraining strategic options.
Weak profitability and returns
Negative net margin and sharply negative ROE indicate the business is destroying shareholder value. Continued losses will deplete equity, raise funding needs, and may necessitate cost cuts or dilution, undermining long-term competitiveness and investor confidence.

Mannatech (MTEX) vs. SPDR S&P 500 ETF (SPY)

Mannatech Business Overview & Revenue Model

Company DescriptionMannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.
How the Company Makes MoneyMannatech generates revenue primarily through the direct sales of its products by a network of independent distributors. The company utilizes a multi-level marketing (MLM) structure, where distributors earn commissions based on their sales and the sales made by their recruited downline. Key revenue streams include the sale of dietary supplements, skincare products, and personal care items. Additionally, Mannatech may engage in partnerships with various health and wellness organizations to enhance product visibility and reach. The company also benefits from its focus on product innovation and customer loyalty programs, which help sustain ongoing sales and repeat business.

Mannatech Financial Statement Overview

Summary
Revenue is declining (-2.27% TTM) with negative profitability (net margin -1.50%) and weak operating metrics (low EBIT/EBITDA margins). Leverage is manageable (debt-to-equity 0.87), but negative ROE (-22.75%) and negative operating/free cash flow signal elevated business and funding risk.
Income Statement
45
Neutral
Mannatech's income statement shows a declining revenue trend with a negative revenue growth rate of -2.27% in the TTM period. The gross profit margin remains relatively strong at 75.69%, but the net profit margin is negative at -1.50%, indicating profitability challenges. The EBIT and EBITDA margins are also low, suggesting operational inefficiencies.
Balance Sheet
55
Neutral
The balance sheet reveals a moderate debt-to-equity ratio of 0.87, indicating manageable leverage. However, the return on equity is negative at -22.75%, reflecting poor profitability relative to shareholder equity. The equity ratio is not provided, but the overall financial stability appears to be under pressure due to declining equity.
Cash Flow
40
Negative
Cash flow analysis shows a concerning trend with negative operating cash flow and free cash flow in the TTM period. Although there is a positive free cash flow growth rate of 28.81%, the operating cash flow to net income ratio is negative, highlighting cash flow challenges. The free cash flow to net income ratio is relatively high at 79.43%, indicating some efficiency in converting income to cash.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue110.41M117.87M131.96M137.21M159.76M151.41M
Gross Profit82.95M91.46M102.86M102.52M125.61M113.91M
EBITDA1.76M5.55M498.00K3.02M10.61M9.66M
Net Income-1.66M2.49M-2.24M-4.49M9.84M6.26M
Balance Sheet
Total Assets33.92M36.06M41.21M49.13M59.63M65.33M
Cash, Cash Equivalents and Short-Term Investments7.69M11.40M7.73M13.78M24.18M22.21M
Total Debt8.10M6.69M5.71M6.21M1.83M2.83M
Total Liabilities26.97M27.44M30.72M34.95M35.21M39.36M
Stockholders Equity6.95M8.61M10.48M14.18M24.41M25.97M
Cash Flow
Free Cash Flow-3.97M1.96M-3.12M-3.66M10.12M5.08M
Operating Cash Flow-2.89M2.26M-2.37M-2.60M10.77M6.03M
Investing Cash Flow-1.06M-285.00K-747.00K-1.06M-650.00K-947.00K
Financing Cash Flow-1.22M1.96M-1.90M-4.33M-9.29M-9.92M

Mannatech Technical Analysis

Technical Analysis Sentiment
Negative
Last Price7.95
Price Trends
50DMA
8.34
Negative
100DMA
8.70
Negative
200DMA
9.02
Negative
Market Momentum
MACD
-0.20
Negative
RSI
45.46
Neutral
STOCH
65.01
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MTEX, the sentiment is Negative. The current price of 7.95 is above the 20-day moving average (MA) of 7.70, below the 50-day MA of 8.34, and below the 200-day MA of 9.02, indicating a bearish trend. The MACD of -0.20 indicates Negative momentum. The RSI at 45.46 is Neutral, neither overbought nor oversold. The STOCH value of 65.01 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MTEX.

Mannatech Risk Analysis

Mannatech disclosed 39 risk factors in its most recent earnings report. Mannatech reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Mannatech Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
61
Neutral
$505.54M4.7714.55%2.39%-12.10%
61
Neutral
$214.18M15.1515.38%-5.47%13.42%
58
Neutral
$953.92M38.271.62%3.51%-1.34%-73.59%
55
Neutral
$13.21M2.0316.79%7.75%-21.61%
51
Neutral
$184.88M-5.84-18.73%-13.14%57.98%
46
Neutral
$14.43M-8.61-19.54%-9.17%-4.64%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MTEX
Mannatech
7.59
-3.91
-34.00%
NUS
Nu Skin
10.37
4.04
63.82%
EPC
Edgewell Personal Care
20.42
-10.79
-34.56%
SKIN
Beauty Health
1.29
-0.33
-20.37%
EWCZ
European Wax Center
3.95
-2.84
-41.83%
TKLF
Yoshitsu Co. Ltd. Sponsored ADR
3.01
-0.79
-20.79%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 16, 2026